High-grade B-cell Lymphoma (HGBCL)
10 clinical trials · Condition
◉ Watch High-grade B-cell Lymphoma (HGBCL)
| Record | Firm | Date |
|---|---|---|
| DALY II USA/ MB-CART2019.1 for DLBCL (NCT04792489) | Miltenyi Biomedicine GmbH | 2021-05-25 |
| Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy (NCT04745559) | H. Lee Moffitt Cancer Center and Research Institute | 2021-02-18 |
| Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma (NCT02348216) | Kite, A Gilead Company | 2015-04-21 |
| A Compassionate Use (CU) Program of Odronextamab (NCT05619367) | Regeneron Pharmaceuticals | |
| Expanded Access Program for Epcoritamab (NCT05733650) | Genmab |
Track High-grade B-cell Lymphoma (HGBCL) automatically
Every clearance here is in the API, with alerts when new ones post.